Cargando…

Interplay between Type 2 Transglutaminase (TG2), Gliadin Peptide 31-43 and Anti-TG2 Antibodies in Celiac Disease

Celiac disease (CD) is a common intestinal inflammatory disease involving both a genetic background and environmental triggers. The ingestion of gluten, a proteic component of several cereals, represents the main hexogen factor implied in CD onset that involves concomitant innate and adaptive immune...

Descripción completa

Detalles Bibliográficos
Autores principales:	Martucciello, Stefania, Sposito, Silvia, Esposito, Carla, Paolella, Gaetana, Caputo, Ivana
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7279455/ https://www.ncbi.nlm.nih.gov/pubmed/32456177 http://dx.doi.org/10.3390/ijms21103673

Ejemplares similares

Constitutive Differential Features of Type 2 Transglutaminase in Cells Derived from Celiac Patients and from Healthy Subjects
por: Paolella, Gaetana, et al.
Publicado: (2020)

Peculiar Ca(2+) Homeostasis, ER Stress, Autophagy, and TG2 Modulation in Celiac Disease Patient-Derived Cells
por: Sposito, Silvia, et al.
Publicado: (2023)

Gliadin Peptides Induce Tissue Transglutaminase Activation and ER-Stress through Ca(2+) Mobilization in Caco-2 Cells
por: Caputo, Ivana, et al.
Publicado: (2012)

Type 2 Transglutaminase in Coeliac Disease: A Key Player in Pathogenesis, Diagnosis and Therapy
por: Paolella, Gaetana, et al.
Publicado: (2022)

Celiac Anti-Type 2 Transglutaminase Antibodies Induce Phosphoproteome Modification in Intestinal Epithelial Caco-2 Cells
por: Paolella, Gaetana, et al.
Publicado: (2013)

TG2-gluten complexes as antigens for gluten-specific and transglutaminase-2 specific B cells in celiac disease
por: Lindstad, Christian B., et al.
Publicado: (2021)

Discovery and Characterization of PROTACs Targeting Tissue Transglutaminase (TG2)
por: Valdivia, Andres, et al.
Publicado: (2023)

Serum and salivary tissue transglutaminase IGA (tTG-IGA) level in celiac patients
por: Ajdani, Mehran, et al.
Publicado: (2022)

Increased Osteoclastogenesis in Absence of TG2 Is Reversed by Transglutaminase Inhibition—Evidence for the Role for TG1 in Osteoclast Formation
por: Ebrahimi Samani, Sahar, et al.
Publicado: (2023)

Celiac Disease–Specific TG2-Targeted Autoantibodies Inhibit Angiogenesis Ex Vivo and In Vivo in Mice by Interfering with Endothelial Cell Dynamics
por: Kalliokoski, Suvi, et al.
Publicado: (2013)

Phosphorylation of transglutaminase 2 (TG2) at serine-216 has a role in TG2 mediated activation of nuclear factor-kappa B and in the downregulation of PTEN
por: Wang, Yi, et al.
Publicado: (2012)

Enzymatic Strategies to Detoxify Gluten: Implications for Celiac Disease
por: Caputo, Ivana, et al.
Publicado: (2010)

Correction: Celiac Disease–Specific TG2-Targeted Autoantibodies Inhibit Angiogenesis Ex Vivo and In Vivo in Mice by Interfering with Endothelial Cell Dynamics
por: Kalliokoski, Suvi, et al.
Publicado: (2014)

Tissue Transglutaminase (TG2)-Induced Inflammation in Initiation, Progression, and Pathogenesis of Pancreatic Cancer
por: Mehta, Kapil, et al.
Publicado: (2011)

Celiac disease TG2 autoantibodies development: it takes two to tango
por: Rossin, Federica, et al.
Publicado: (2020)

Gliadin Peptide P31-43 Localises to Endocytic Vesicles and Interferes with Their Maturation
por: Barone, Maria Vittoria, et al.
Publicado: (2010)

Using TG1 and TG2's with cycle lengths > 32 s
por: Beetham, D
Publicado: (1983)

Effect of transglutaminase 2 (TG2) deficiency on atherosclerotic plaque stability in the apolipoprotein E deficient mouse
por: Williams, Helen, et al.
Publicado: (2010)

Tissue transglutaminase (TG2) activity regulates osteoblast differentiation and mineralization in the SAOS-2 cell line
por: Yin, Xiaoxue, et al.
Publicado: (2012)

Tissue transglutaminase (TG2) enables survival of human malignant pleural mesothelioma cells in hypoxia
por: Zonca, Sara, et al.
Publicado: (2017)

Dihydroisoxazole inhibitors of Anopheles gambiae seminal transglutaminase AgTG3
por: Le, Binh V, et al.
Publicado: (2014)

Towards Celiac-safe foods: Decreasing the affinity of transglutaminase 2 for gliadin by addition of ascorbyl palmitate and ZnCl(2) as detoxifiers
por: Engstrom, N., et al.
Publicado: (2017)

Pro-Apoptotic and Pro-Autophagic Properties of Cardenolides from Aerial Parts of Pergularia tomentosa
por: Martucciello, Stefania, et al.
Publicado: (2022)

The Multifaceted Role of HSF1 in Pathophysiology: Focus on Its Interplay with TG2
por: Occhigrossi, Luca, et al.
Publicado: (2021)

Urinary levels of pro-fibrotic transglutaminase 2 (TG2) may help predict progression of chronic kidney disease
por: Da Silva Lodge, Michelle, et al.
Publicado: (2022)

Protective immunity induced by DNA vaccine containing TgGRA35, TgGRA42, and TgGRA43 against Toxoplasma gondii infection in Kunming mice
por: Shi, Youbo, et al.
Publicado: (2023)

Expression of Functional Recombinant Human Tissue Transglutaminase (TG2) Using the Bac-to-Bac Baculovirus Expression System
por: Yazdani, Yaghoub, et al.
Publicado: (2016)

The gliadin peptide 31-43 exacerbates kainate neurotoxicity in epilepsy models
por: Gerace, Elisabetta, et al.
Publicado: (2017)

Gamma-gliadin specific celiac disease antibodies recognize p31-43 and p57-68 alpha gliadin peptides in deamidation related manner as a result of cross-reaction
por: Diós, Ádám, et al.
Publicado: (2021)

Beyond the Intestinal Celiac Mucosa: Diagnostic Role of Anti-TG2 Deposits, a Systematic Review
por: Gatti, Simona, et al.
Publicado: (2014)

A Celiac Cellular Phenotype, with Altered LPP Sub-Cellular Distribution, Is Inducible in Controls by the Toxic Gliadin Peptide P31-43
por: Nanayakkara, Merlin, et al.
Publicado: (2013)

Determination of TG-43 Dosimetric Parameters for Photon Emitting Brachytherapy Sources
por: A., Mozaffari, et al.
Publicado: (2019)

Immunization With a DNA Vaccine Cocktail Encoding TgPF, TgROP16, TgROP18, TgMIC6, and TgCDPK3 Genes Protects Mice Against Chronic Toxoplasmosis
por: Zhang, Nian-Zhang, et al.
Publicado: (2018)

Secretion of celiac disease autoantibodies after in vitro gliadin challenge is dependent on small-bowel mucosal transglutaminase 2-specific IgA deposits
por: Stenman, Satumarja M, et al.
Publicado: (2008)

Perturbation of TG‐43 parameters of the brachytherapy sources under insufficient scattering materials
por: Zehtabian, Mehdi, et al.
Publicado: (2013)

TG 12 (A)
Publicado: (2017)

Sourdough Fermentation of Wheat Flour does not Prevent the Interaction of Transglutaminase 2 with α(2)-Gliadin or Gluten
por: Engström, Niklas, et al.
Publicado: (2015)

The influence of thyroid status, serum Tg, TSH, and TgAb on FNA‐Tg in cervical metastatic lymph nodes of papillary thyroid carcinoma
por: Sun, Jingjing, et al.
Publicado: (2021)

P31–43, an undigested gliadin peptide, mimics and enhances the innate immune response to viruses and interferes with endocytic trafficking: a role in celiac disease
por: Nanayakkara, Merlin, et al.
Publicado: (2018)

The Intestinal T Cell Response to α-Gliadin in Adult Celiac Disease Is Focused on a Single Deamidated Glutamine Targeted by Tissue Transglutaminase
por: Arentz-Hansen, Helene, et al.
Publicado: (2000)

Cannot write session to /tmp/vufind_sessions/sess_v4d5ir6ddk9k32cogskhkhisni